Home › Funds › LOCKHEED MARTIN INVESTMENT MANAGEMENT CO › CME

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO position in CME

CME GROUP INC · Financials

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO reported holding 37,350 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$9.8M, representing 0.70% of its reported portfolio and ranking #31 among its reported holdings. LOCKHEED MARTIN INVESTMENT MANAGEMENT CO has disclosed CME holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)37.35K sh
Reported value held$9.78M
Portfolio Weight0.70%
First reportedQ1 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LOCKHEED MARTIN INVESTMENT MANAGEMENT CO's CME position evolved

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO first disclosed a stake in CME in Q1 2024 at 43,730 shares (US$9.3M). The position peaked in Q1 2026 at 59,970 shares, worth US$17.7M. Across 11 filings, LOCKHEED MARTIN INVESTMENT MANAGEMENT CO increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 37,350 shares valued at US$9.8M — a reduction of -21,320 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2024 (shares rose 5% over the following quarter), a 34% increase in Q1 2025 (shares rose 4% over the following quarter), a 36% trim in Q3 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 43.73K $9.32M New
Q2 2024 42.22K $8.30M Reduce
Q3 2024 54.02K $11.92M Add
Q4 2024 43.78K $10.17M Reduce
Q1 2025 58.69K $15.57M Add
Q2 2025 54.96K $15.15M Reduce
Q3 2025 52.99K $14.32M Reduce
Q4 2025 59.33K $16.20M Add
Q1 2026 59.97K $17.71M Add
Q2 2026 58.67K $12.96M Reduce
Q3 2026 37.35K $9.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CME and 13F data

CME (CME GROUP INC) is a Financials company. 25 other funds we track also report a position in CME — the largest reported positions include Sanders Capital, LLC (US$1.33B), RAYMOND JAMES FINANCIAL INC (US$1.08B), Fidelity International (FIL) (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CME

All CME fund holders →

FAQ

How long has LOCKHEED MARTIN INVESTMENT MANAGEMENT CO held CME?

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO has disclosed CME holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is LOCKHEED MARTIN INVESTMENT MANAGEMENT CO's current position in CME?

As of Q3 2026, LOCKHEED MARTIN INVESTMENT MANAGEMENT CO holds 37.35K shares of CME (CME GROUP INC), valued at $9.78M, representing 0.70% of its reported portfolio and ranking #31.

Has LOCKHEED MARTIN INVESTMENT MANAGEMENT CO been buying or selling CME?

In the latest 13F filing (Q3 2026), LOCKHEED MARTIN INVESTMENT MANAGEMENT CO reduced its position in CME. The position peaked in Q1 2026 at 59.97K shares.

Which other funds hold CME?

Other major institutional holders of CME include Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, Fidelity International (FIL), among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.